Recently, the ATX-LPA axis was demonstrated to modulate the innate immune response in patients with acute liver failure via lysophosphatidic acid receptor 1 (LPAR1) and lysophosphatidic acid receptor 3 (LPAR3) [4]. Here, LPAR3 is linked to acute liver failure.